Toggle Dropdown
Announcements
Projects
Welcome guest
Log in
Loading
Loading...
https://www.investors.com/news/technology/crispr-stock-rises-ahead-of-expected-fda-approval-of-gene-editing-treatment/
0
0
Crispr Whipsaws Lower After FDA OKs Gene-Editing Treatment - Investor's Business Daily
12/8/23 at 1:37pm
Organization
Investor's Business Daily
Author
Investor's Business Daily
Details
22 words
Summarize
Pharmaceuticals & Biotech
Biological Sciences
Business & Industrial
Crispr Whipsaws Lower
OKs Gene-Editing Treatment - Investor's Business Daily
FDA
The groundbreaking approval was a sell the news event.
Show more
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...